title: Effects of omega-3 fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus, and osteoporosis.
authors.forename: C H
authors.initials: CH
authors.lastname: MacLean
authors.forename: W A
authors.initials: WA
authors.lastname: Mojica
authors.forename: S C
authors.initials: SC
authors.lastname: Morton
authors.forename: J
authors.initials: J
authors.lastname: Pencharz
authors.forename: R
authors.initials: R
authors.lastname: Hasenfeld Garland
authors.forename: W
authors.initials: W
authors.lastname: Tu
authors.forename: S J
authors.initials: SJ
authors.lastname: Newberry
authors.forename: L K
authors.initials: LK
authors.lastname: Jungvig
authors.forename: J
authors.initials: J
authors.lastname: Grossman
authors.forename: P
authors.initials: P
authors.lastname: Khanna
authors.forename: S
authors.initials: S
authors.lastname: Rhodes
authors.forename: P
authors.initials: P
authors.lastname: Shekelle
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000178:diet therapy* / Q000188:drug therapy; D015519:Bone Density; D002648:Child; D003924:Diabetes Mellitus, Type 2 / Q000178:diet therapy* / Q000378:metabolism; D015525:Fatty Acids, Omega-3 / Q000494:pharmacology* / Q000502:physiology / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015212:Inflammatory Bowel Diseases / Q000178:diet therapy* / Q000188:drug therapy; D007674:Kidney Diseases / Q000178:diet therapy* / Q000188:drug therapy; D008180:Lupus Erythematosus, Systemic / Q000178:diet therapy*; D015201:Meta-Analysis as Topic; D024821:Metabolic Syndrome / Q000178:diet therapy* / Q000378:metabolism; D010024:Osteoporosis / Q000178:diet therapy*; D010919:Placebos; D016032:Randomized Controlled Trials as Topic
chemical_list: D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D015525:Fatty Acids, Omega-3; D007166:Immunosuppressive Agents; D010919:Placebos